-
EP3684822
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3684822
| EP3684822 - NOVEL ANTI-HLA-A2 ANTIBODIES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 26.06.2020 Database last updated on 03.09.2024 | |
| Former | The international publication has been made Status updated on 30.03.2019 | Most recent event Tooltip | 27.09.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states The University of British Columbia University - Industry Liaison Office 103-6190 Agronomy Road Vancouver, British Columbia V6T 1Z3 / CA | For all designated states Sangamo Therapeutics France Allée de la Nertière Les Cardoulines 06560 Valbonne Sophia Antipolis / FR | [2020/31] | Inventor(s) | 01 /
ZHOU, Li 93 Searle Road West Roxbury, Massachusetts 02132 / US | 02 /
ABEL, Tobias 1 avenue de la Libération Résidence Port Vauban Appt A 206 06600 Antibes / FR | 03 /
MEYER, François Chemin des Minoux 27 2900 Porrentruy / CH | 04 /
LEVINGS, Megan 3435 West 15th Avenue Vancouver, British Columbia V6R 2Z2 / CA | 05 /
DAWSON, Nicolas 304-995 West 59th Avenue Vancouver, British Columbia V6P 6Z2 / CA | 06 /
LAMARCHE, Caroline 703-456 Moberly Avenue Vancouver, British Columbia V5Z 4L7 / CA | [2020/31] | Representative(s) | Icosa 83 avenue Denfert-Rochereau 75014 Paris / FR | [2020/31] | Application number, filing date | 18859115.0 | 20.09.2018 | [2020/31] | WO2018CA51174 | Priority number, date | US201762560841P | 20.09.2017 Original published format: US 201762560841 P | US201862691027P | 28.06.2018 Original published format: US 201862691027 P | [2020/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019056106 | Date: | 28.03.2019 | Language: | EN | [2019/13] | Type: | A1 Application with search report | No.: | EP3684822 | Date: | 29.07.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.03.2019 takes the place of the publication of the European patent application. | [2020/31] | Search report(s) | International search report - published on: | CA | 28.03.2019 | (Supplementary) European search report - dispatched on: | EP | 19.05.2021 | Classification | IPC: | C07K16/46, A61K35/17, A61P37/06, C07K14/705, C07K16/28, C07K19/00, C12N15/13, C12N15/62, C12N5/10 | [2020/31] | CPC: |
A61P37/06 (EP,IL,KR);
C07K16/2833 (EP,IL,KR,US);
A61K35/17 (US);
A61K39/4611 (EP,IL,KR);
A61K39/4621 (EP,IL);
A61K39/4631 (EP,IL,KR);
A61K39/46434 (EP,IL);
C07K14/7051 (EP,IL,KR,US);
C07K14/70517 (EP,IL,KR,US);
C07K14/70575 (US);
C07K14/70578 (EP,IL,KR);
C12N15/62 (EP,IL,KR);
A61K2035/122 (US);
A61K2121/00 (KR);
A61K2300/00 (KR);
C07K2317/24 (EP,IL,KR,US);
C07K2317/33 (EP,IL,KR,US);
C07K2317/622 (EP,IL,KR,US);
C07K2319/00 (EP,IL);
C07K2319/02 (EP,IL,KR,US);
C07K2319/03 (EP,IL,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/31] | Title | German: | NEUE ANTI-HLA-A2-ANTIKÖRPER UND VERWENDUNGEN DAVON | [2020/31] | English: | NOVEL ANTI-HLA-A2 ANTIBODIES AND USES THEREOF | [2020/31] | French: | NOUVEAUX ANTICORPS ANTI-HLA-A2 ET LEURS UTILISATIONS | [2020/31] | Entry into regional phase | 20.04.2020 | National basic fee paid | 20.04.2020 | Search fee paid | 20.04.2020 | Designation fee(s) paid | 20.04.2020 | Examination fee paid | Examination procedure | 20.04.2020 | Examination requested [2020/31] | 24.05.2021 | Observations by third parties | 09.12.2021 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.08.2020 | Renewal fee patent year 03 | 27.09.2021 | Renewal fee patent year 04 | 27.09.2022 | Renewal fee patent year 05 | 27.09.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2011058321 (KING S COLLEGE HOSPITAL NHS FOUNDATION TRUST [GB], et al); | other | WO2019056099 |